Home › Schizophrenia › Nevada › Las Vegas
Schizophrenia clinical trials in Las Vegas, NV
7 studies for Schizophrenia are looking for participants at sites in and around Las Vegas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
RecruitingPhase 3
- Clinical Research of Southern Nevada, LLC, Las Vegas
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
RecruitingPhase 3
- Local Institution - 0144, Las Vegas
52-week Open Label Safety-Tolerability Study
RecruitingPhase 3
- Redbird Research, Las Vegas
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
RecruitingPhase 2
- Clinical Site, Las Vegas
- Clinical Site, Las Vegas
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
RecruitingObservational study
- Local Institution - 0055, Las Vegas
A Study to Evaluate the Effect of KarXT on Urological Safety
RecruitingPhase 4
- IMA Clinical Research Las Vegas, Las Vegas
Randomized Withdrawal Study in Patients With Schizophrenia
RecruitingPhase 3
- Vanda Investigational Site, Las Vegas
About Schizophrenia
Schizophrenia is a serious brain illness that can include hearing voices that aren't there and thinking others are trying to hurt them.
More about Schizophrenia on MedlinePlus
Schizophrenia trials in other cities
- Atlanta, GA22 studies
- Chicago, IL21 studies
- Little Rock, AR19 studies
- Hollywood, FL15 studies
- Boston, MA14 studies
- Houston, TX13 studies
- San Diego, CA13 studies
- New York City, NY13 studies
- Hialeah, FL13 studies
- Austin, TX13 studies
- Garden Grove, CA12 studies
- Germantown, MD11 studies
Other studies in Las Vegas
- Obesity27 studies
- Overweight23 studies
- Type 2 Diabetes18 studies
- Non-Small Cell Lung Cancer13 studies
- Major Depressive Disorder13 studies
- Breast Cancer10 studies
- Alzheimer's Disease8 studies
- Prostate Cancer8 studies
- Acute Myeloid Leukemia8 studies
- Cancer (all types)8 studies
- Steatotic Liver Disease7 studies
- Endometrial Cancer7 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.